Jon Congleton - 29 Apr 2026 Form 3 Insider Report for Avalyn Pharma Inc. (AVLN)

Reporting relationship: Director
Issuer ticker: AVLN
Reported as of: 29 Apr 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 29 Apr 2026, 18:43:23 UTC
Prior SEC filing: 15 Apr 2026
Next SEC filing: 29 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Douglas Carlson

Key filing fact

Jon Congleton filed Form 3 for Avalyn Pharma Inc. (AVLN) on 29 Apr 2026.

Key facts

This page summarizes Jon Congleton's Form 3 filing for Avalyn Pharma Inc. (AVLN).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 29 Apr 2026, 18:43.

Change

Previous filing in this sequence was filed on 15 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001644975 Primary reporting owner

Congleton Jon

Relationship: Director
Address: 105 W FIRST STREET, BOSTON
Signature: /s/ Douglas Carlson
Signature date: 29 Apr 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AVLN holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 29 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 43,928
Exercise price: $11.74
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1/8th of the shares underlying this option vest and become exercisable in substantially equal quarterly installments on each quarterly anniversary of April 3, 2026, subject to the Reporting Person's continued service on each such vesting date.

SEC remarks

Exhibit 24 - Power of Attorney